Heidi Russell

Summary

Affiliation: Baylor College of Medicine
Country: USA

Publications

  1. doi request reprint Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy
    Heidi Russell
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatr Blood Cancer 53:23-7. 2009
  2. ncbi request reprint Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin
    Heidi V Russell
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Immunother 30:227-33. 2007
  3. doi request reprint A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma
    Heidi V Russell
    Department of Pediatrics, Texas Children s Cancer Center, Houston, TX 77030, USA
    J Immunother 31:812-9. 2008
  4. pmc Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report
    Stacey L Berg
    Texas Children s Cancer Center, 6621 Fannin St, MC3 3320, Houston, TX 77030, USA
    J Clin Oncol 29:316-23. 2011
  5. ncbi request reprint CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases
    Heidi V Russell
    Texas Children s Cancer Center and Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    J Pediatr Surg 39:1506-11. 2004
  6. ncbi request reprint The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma
    Heidi V Russell
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatr Blood Cancer 45:916-9. 2005
  7. pmc Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients
    Andre N Gay
    Division of Pediatric Surgery, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030 2399, USA
    J Pediatr Surg 43:837-42. 2008
  8. ncbi request reprint Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group
    Heidi Russell
    Texas Children s Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas University of Texas School of Public Health, Division of Management, Policy and Community Health, Houston, Texas
    Pediatr Blood Cancer 61:970-6. 2014
  9. ncbi request reprint Congenital neuroblastoma in a neonate with isotretinoin embryopathy
    Shiley Aguilar
    Texas Children s Cancer Center Department of Pathology, Baylor College of Medicine, Houston, TX
    J Pediatr Hematol Oncol 36:e75-7. 2014
  10. doi request reprint Refractory dilated cardiomyopathy associated with metastatic neuroblastoma
    Peter Carlson
    Baylor College of Medicine, Houston, Texas, USA
    Pediatr Blood Cancer 55:736-8. 2010

Collaborators

  • Eric Yvon
  • Raphael Rousseau
  • David Walterhouse
  • Douglas S Hawkins
  • Mehmet Fatih Okcu
  • A P Gee
  • John Hicks
  • C Rossig
  • Ettore Biagi
  • H E Heslop
  • Rachel A Egler
  • M J Hicks
  • Sanjeev A Vasudevan
  • Xiaoying Shang
  • Susan M Burlingame
  • Jianhua Yang
  • Jed G Nuchtern
  • Shiley Aguilar
  • Stacey L Berg
  • Peter Carlson
  • Ningling Ge
  • Shirong Chang
  • Martin A Pule
  • Andre N Gay
  • Peter Zage
  • Chrystal Louis
  • Mitchell S Cairo
  • Nianhang Chen
  • Henry Lau
  • Peter C Adamson
  • Janet Ayello
  • Susan M Blaney
  • Ashish Mark Ingle
  • John L Jefferies
  • Debra Kearney
  • Catherine L Wesson
  • Rodney D David
  • Xiaoyi Shang
  • Jose L Diaz-Miron
  • Javed Khan
  • Eugene S Kim
  • Andrew D Ludwig
  • Enli Liu
  • Hao Liu
  • Gianpietro Dotti
  • Sarah Byeseda
  • G Doug Myers
  • Oluyinka O Olutoye
  • Bindi Naik-Mathuria
  • Barbara Savoldo
  • Heidi L Weiss
  • Darrell L Cass
  • Zhuyong Mei
  • Lindsey Rutland
  • Cliona M Rooney
  • Malcolm K Brenner
  • Ling Yu
  • M Helen Huls
  • Zhiyun J Liu

Detail Information

Publications16

  1. doi request reprint Infantile fibrosarcoma: clinical and histologic responses to cytotoxic chemotherapy
    Heidi Russell
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatr Blood Cancer 53:23-7. 2009
    ..This report describes the histologic changes and outcomes in four patients with IF treated with chemotherapy and surgical resection...
  2. ncbi request reprint Phase I trial of vaccination with autologous neuroblastoma tumor cells genetically modified to secrete IL-2 and lymphotactin
    Heidi V Russell
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
    J Immunother 30:227-33. 2007
    ..In this setting, the immune response was insufficient to overcome active recurrent neuroblastoma...
  3. doi request reprint A phase 1/2 study of autologous neuroblastoma tumor cells genetically modified to secrete IL-2 in patients with high-risk neuroblastoma
    Heidi V Russell
    Department of Pediatrics, Texas Children s Cancer Center, Houston, TX 77030, USA
    J Immunother 31:812-9. 2008
    ..Median event-free survival was 22 months for patients in first remission and 3 months for all others. Four patients treated in first remission remain alive and 3 without disease recurrence...
  4. pmc Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report
    Stacey L Berg
    Texas Children s Cancer Center, 6621 Fannin St, MC3 3320, Houston, TX 77030, USA
    J Clin Oncol 29:316-23. 2011
    ....
  5. ncbi request reprint CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases
    Heidi V Russell
    Texas Children s Cancer Center and Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA
    J Pediatr Surg 39:1506-11. 2004
    ..The goal of this study was to investigate whether the degree of expression of CXCR4 on cells from neuroblastoma primary tumors was related to the pattern of metastatic involvement...
  6. ncbi request reprint The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma
    Heidi V Russell
    Texas Children s Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Pediatr Blood Cancer 45:916-9. 2005
    ..If stage of disease rarely changed with bone marrow results, it might be possible to avoid this procedure in a subset of patients with neuroblastoma...
  7. pmc Granulocyte colony stimulating factor alters the phenotype of neuroblastoma cells: implications for disease-free survival of high-risk patients
    Andre N Gay
    Division of Pediatric Surgery, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030 2399, USA
    J Pediatr Surg 43:837-42. 2008
    ..We hypothesized that exogenous GCSF stimulates the proliferation and invasive character of neuroblastoma cells...
  8. ncbi request reprint Cost minimization analysis of two treatment regimens for low-risk rhabdomyosarcoma in children: a report from the Children's Oncology Group
    Heidi Russell
    Texas Children s Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas University of Texas School of Public Health, Division of Management, Policy and Community Health, Houston, Texas
    Pediatr Blood Cancer 61:970-6. 2014
    ..Failure-free survival was similar. We undertook a cost minimization comparison to help guide future decision-making...
  9. ncbi request reprint Congenital neuroblastoma in a neonate with isotretinoin embryopathy
    Shiley Aguilar
    Texas Children s Cancer Center Department of Pathology, Baylor College of Medicine, Houston, TX
    J Pediatr Hematol Oncol 36:e75-7. 2014
    ..Because of the uncertain etiology of neuroblastoma, it remains unclear whether exposure to isotretinoin during embryogenesis and fetal development had an oncogenic effect on this patient. ..
  10. doi request reprint Refractory dilated cardiomyopathy associated with metastatic neuroblastoma
    Peter Carlson
    Baylor College of Medicine, Houston, Texas, USA
    Pediatr Blood Cancer 55:736-8. 2010
    ..However, the tumor proved unresponsive to treatment. The patient died from stage IV congestive heart failure (CHF) and progressive NB. Autopsy confirmed dilated cardiomyopathy with endocardial fibroelastosis...
  11. ncbi request reprint Flow cytometry and fluorescence in situ hybridization to detect residual neuroblastoma cells in bone marrow
    Mehmet Fatih Okcu
    Division of Pediatrics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Pediatr Blood Cancer 45:787-95. 2005
    ..In patients with neuroblastoma morphological assessment of BM for residual NB cells is not precise, particularly when the number of tumor cells is small...
  12. pmc Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
    Martin A Pule
    Center for Cell and Gene Therapy, Baylor College of Medicine and The Methodist Hospital and Texas Children s Hospital, Houston, Texas 77030, USA
    Nat Med 14:1264-70. 2008
    ..Infusion of these genetically modified cells seemed safe and was associated with tumor regression or necrosis in half of the subjects tested. Hence, virus-specific CTLs can be modified to function as tumor-directed effector cells...
  13. pmc Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma
    Sanjeev A Vasudevan
    Michael E DeBakey Department of Surgery, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Mol Cancer Ther 8:2478-89. 2009
    ..Furthermore, NDSP serves as a growth factor for neuroblastoma tumor cells through activation of the ERK-mediated proliferation pathway...
  14. pmc Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma
    Xiaoying Shang
    Texas Children s Cancer Center, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
    Mol Cancer Ther 8:2461-9. 2009
    ..Overexpression of Aurora A is associated with disease progression in neuroblastoma. Inhibition of this kinase is a promising modality for neuroblastoma treatment...
  15. pmc Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma
    Rachel A Egler
    Department of Pediatrics, Texas Children s Cancer Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Cancer Res 14:7028-34. 2008
    ..To explore the relationships between interleukin-6 (IL-6) and soluble IL-6 receptor (sIL-6R) levels and disease extent and clinical outcome in childhood neuroblastoma...
  16. ncbi request reprint Neuroblastoma-derived secretory protein messenger RNA levels correlate with high-risk neuroblastoma
    Sanjeev A Vasudevan
    Division of Pediatric Surgery, Michael E DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
    J Pediatr Surg 42:148-52. 2007
    ..The need to detect residual disease and predict prognosis is critical to planning appropriate treatment regimens for these patients. Recently, neuroblastoma-derived secretory protein (NDSP) was identified and cloned from neuroblastoma...